India’s ‘Health for All’ Campaign Faces Funding Deficits and Quality Control Issues
India's "health for all" initiative is struggling due to a persistent funding deficit, with health spending remaining below 2% of GDP against a target of 2.5%. The withdrawal of U.S. funding through USAID and PEPFAR in early 2025 has further strained key health programs. Major challenges include the rise of Antimicrobial Resistance (AMR), the failure to meet the 2025 TB elimination goal, and critical quality control failures in the pharmaceutical industry, highlighted by deaths linked to contaminated cough syrups. While diagnostic access has improved, the gap between demand and supply in infrastructure remains significant, requiring urgent realignment of priorities.
Key Points
- India's health budget is currently below 2% of GDP, missing the National Health Policy target of 2.5%.
- Antimicrobial Resistance (AMR) is a growing concern, with high resistance rates in hospital-acquired infections like E.coli.
- The target to eliminate Tuberculosis by 2025 remains unachieved despite advancements in home-grown molecular tests.
- Recent deaths from contaminated cough syrups have raised serious concerns about the pharma quality regulatory framework.
Exam Facts
- The National Health Policy sets a target of 2.5% of GDP for health spending.
- 25 children died in Madhya Pradesh due to contaminated cough syrup consumption.
- The WHO's GLASS report highlights India's high rates of antimicrobial resistance compared to global averages.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.